338760-63-7 Usage
Description
METHYL1,6-NAPHTHYRIDINE-2-CARBOXYLATE, with the molecular formula C13H11NO2, is a chemical compound that is a derivative of naphthyridine carboxylic acid. It features a methyl group attached to the naphthyridine ring, which contributes to its unique chemical properties and potential applications.
Uses
Used in Pharmaceutical Industry:
METHYL1,6-NAPHTHYRIDINE-2-CARBOXYLATE is used as an intermediate in the synthesis of various drugs. Its unique structure allows it to be a key component in the development of new pharmaceuticals with potential therapeutic benefits.
Used in Agrochemical Industry:
METHYL1,6-NAPHTHYRIDINE-2-CARBOXYLATE is used as an intermediate in the synthesis of pesticides. Its chemical properties make it a valuable component in creating effective and targeted agrochemicals for pest control.
Used in Antimalarial Applications:
METHYL1,6-NAPHTHYRIDINE-2-CARBOXYLATE is used as an antimalarial agent. Its pharmacological properties have been studied for their potential to combat malaria, offering a new avenue for treatment and prevention of this disease.
Used in Anti-inflammatory Applications:
METHYL1,6-NAPHTHYRIDINE-2-CARBOXYLATE is used as an anti-inflammatory agent. Its potential to reduce inflammation has been of interest for researchers, as it could lead to the development of new treatments for various inflammatory conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 338760-63-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,8,7,6 and 0 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 338760-63:
(8*3)+(7*3)+(6*8)+(5*7)+(4*6)+(3*0)+(2*6)+(1*3)=167
167 % 10 = 7
So 338760-63-7 is a valid CAS Registry Number.
338760-63-7Relevant articles and documents
Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith
-
Page/Page column 43, (2008/12/07)
Provided herein are Heterocyclic Compounds having the following structure: wherein R1, R2, X, Y and Z are as defined herein, compositions comprising an effective amount of a Heterocyclic Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heterocyclic Compound to a patient in need thereof.
